Publications

  1. Kudva YC, Erickson JR, Parsaik A, Rostambeigi N, Thapa P, Abraham RS. Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients. Hum Immunol. 2013 Jun; 74(6):738-45. Epub 2013 Mar 07. 2309466
    View PubMed
  2. Bower RS, Mallory GW, Nwojo M, Kudva YC, Flemming KD, Meyer FB. Moyamoya Disease in a Primarily White, Midwestern US Population: Increased Prevalence of Autoimmune Disease. Stroke. 2013 May 07. [Epub ahead of print] 2321887
    View PubMed
  3. Bharucha AE, Low P, Camilleri M, Veil E, Burton D, Kudva Y, Shah P, Gehrking T, Zinsmeister AR. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013 May; 62(5):708-15. Epub 2012 Jun 07. 2252464
    View PubMed
  4. Dong M, Parsaik AK, Kremers W, Sun A, Dean P, Prieto M, Cosio FG, Gandhi MJ, Zhang L, Smyrk TC, Stegall MD, Kudva YC. Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation. Am J Transplant. 2013 Apr; 13(4):1019-25. Epub 2013 Feb 22. 2305954
    View PubMed
  5. Ferrara MJ, Lohse C, Kudva YC, Farnell MB, Que FG, Reid-Lombardo KM, Donohue JH, Nagorney DM, Chari ST, Vege SS, Kendrick ML. Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors. HPB (Oxford). 2013 Mar; 15(3):170-4. Epub 2012 Sep 10. 2300844
    View PubMed
  6. Basu A, Kudva YC, Basu R. GPR40 modulators: new kid on the block. Diabetes Care. 2013 Feb; 36(2):185-7. 2307518
    View PubMed
  7. Parsaik AK, Carter RE, Myers LA, Basu A, Kudva YC. Hypoglycemia requiring ambulance services in patients with type 2 diabetes is associated with increased long-term mortality. Endocr Pract. 2013 Jan-Feb; 19(1):29-35. 2286414
    View PubMed
  8. Thatava T, Kudva YC, Edukulla R, Squillace K, De Lamo JG, Khan YK, Sakuma T, Ohmine S, Terzic A, Ikeda Y. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol Ther. 2013 Jan; 21(1):228-39. Epub 2012 Nov 27. 2285781
    View PubMed
  9. Scalzo P, Basu A, Kudva Y. Current state of diabetes technology clinics and programs in the United States. J Diabetes Sci Technol. 2013; 7(3):798-9. Epub 2013 May 01. 2330132
    View PubMed
  10. Manohar C, Levine JA, Nandy DK, Saad A, Dalla Man C, McCrady-Spitzer SK, Basu R, Cobelli C, Carter RE, Basu A, Kudva YC. The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people. Diabetes Care. 2012 Dec; 35(12):2493-9. Epub 2012 Aug 08. 2290866
    View PubMed
  11. Saad A, Dalla Man C, Nandy DK, Levine JA, Bharucha AE, Rizza RA, Basu R, Carter RE, Cobelli C, Kudva YC, Basu A. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes. 2012 Nov; 61(11):2691-700. Epub 2012 Jun 29. 2284673
    View PubMed
  12. Parsaik AK, Carter RE, Myers LA, Geske JR, Smith SA, Levine JA, Basu A, Kudva YC. Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services. Endocr Pract. 2012 Nov-Dec; 18(6):834-41. 2257332
    View PubMed
  13. Spanogle JP, Kudva YC, Dierkhising RA, Kremers WK, Roenigk RK, Brewer JD, Prieto M, Otley CC. Skin cancer after pancreas transplantation. J Am Acad Dermatol. 2012 Oct; 67(4):563-9. Epub 2012 Feb 15. 2226602
    View PubMed
  14. Parsaik AK, Carter RE, Myers LA, Dong M, Basu A, Kudva YC. Outcomes of community-dwelling adults without diabetes mellitus who require ambulance services for hypoglycemia. J Diabetes Sci Technol. 2012 Sep; 6(5):1107-13. Epub 2012 Sep 01. 2277446
    View PubMed
  15. Wauters RP, Cosio FG, Suarez Fernandez ML, Kudva Y, Shah P, Torres VE. Cardiovascular consequences of new-onset hyperglycemia after kidney transplantation. Transplantation. 2012 Aug 27; 94(4):377-82. 2259384
    View PubMed
  16. Dong M, Parsaik AK, Eberhardt NL, Basu A, Cosio FG, Kudva YC. Cellular and physiological mechanisms of new-onset diabetes mellitus after solid organ transplantation. Diabet Med. 2012 Jul; 29(7):e1-12. 2227705
    View PubMed
  17. Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, Oberholzer J, Odorico JS, Garfinkel MR, Levy M, Pattou F, Berney T, Secchi A, Messinger S, Senior PA, Maffi P, Posselt A, Stock PG, Kaufman DB, Luo X, Kandeel F, Cagliero E, Turgeon Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care. 2012 Jul; 35(7):1436-45. 2257599
    View PubMed
  18. Rajagopalan G, Kudva YC, David CS. Is HOT a cool treatment for type 1 diabetes? Diabetes. 2012 Jul; 61(7):1664-6. 2257671
    View PubMed
  19. Buse JB, Kudva YC, Battelino T, Davis SN, Shin J, Welsh JB. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technol Ther. 2012 Jul; 14(7):644-7. Epub 2012 Apr 23. 2262074
    View PubMed
  20. Kudva YC, Ohmine S, Greder LV, Dutton JR, Armstrong A, De Lamo JG, Khan YK, Thatava T, Hasegawa M, Fusaki N, Slack JM, Ikeda Y. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Transl Med. 2012 Jun; 1(6):451-61. Epub 2012 May 30. 2289362
    View PubMed
  21. Dutta T, Chai HS, Ward LE, Ghosh A, Persson XM, Ford GC, Kudva YC, Sun Z, Asmann YW, Kocher JP, Nair KS. Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes. Diabetes. 2012 May; 61(5):1004-16. Epub 2012 Mar 13. 2246457
    View PubMed
  22. Ohmine S, Squillace KA, Hartjes KA, Deeds MC, Armstrong AS, Thatava T, Sakuma T, Terzic A, Kudva Y, Ikeda Y. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging (Albany NY). 2012 Jan; 4(1):60-73. 2222939
    View PubMed
  23. Parsaik AK, Carter RE, Pattan V, Myers LA, Kumar H, Smith SA, Russi CS, Levine JA, Basu A, Kudva YC. Population-based study of severe hypoglycemia requiring emergency medical service assistance reveals unique findings. J Diabetes Sci Technol. 2012 Jan; 6(1):65-73. Epub 2012 Jan 1. 2216257
    View PubMed
  24. Parsaik AK, Carter RE, Myers LA, Geske JR, Smith SA, Levine J, Basu A, Kudva YC. Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services. Endocr Pract. 2012; 18(6):834-41. 2293553
  25. Hiddinga HJ, Sakagashira S, Ishigame M, Madde P, Sanke T, Nanjo K, Kudva YC, Lee JJ, van Deursen J, Eberhardt NL. Expression of wild-type and mutant S20G hIAPP in physiologic knock-in mouse models fails to induce islet amyloid formation, but induces mild glucose intolerance. Journal of Diabetes Investigation. 2012; 3(2):138-47. 2238425
  26. Dong M, Parsaik AK, Erwin PJ, Farnell MB, Murad MH, Kudva YC. Systematic review and meta-analysis: islet autotransplantation after pancreatectomy for minimizing diabetes. Clin Endocrinol (Oxf). 2011 Dec; 75(6):771-9. 2166899
    View PubMed
  27. Parsaik AK, Bhalla T, Dong M, Rostambeigi N, Dierkhising RA, Dean P, Abraham R, Prieto M, Kremers WK, Razonable RR, Kudva YC. Epidemiology of cytomegalovirus infection after pancreas transplantation. Transplantation. 2011 Nov 15; 92(9):1044-50. 2189269
    View PubMed
  28. Pattan V, Parsaik A, Brown JK, Kudva YC, Vlahakis N, Basu A. Glucose control in Mayo Clinic intensive care units. J Diabetes Sci Technol. 2011 Nov; 5(6):1420-6. Epub 2011 Nov 01. 2216498
    View PubMed
  29. Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, Eberhardt NL, Kudva YC. Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab Anim. 2011 Jul; 45(3):131-40. Epub 2011 Apr 08. 2157452
    View PubMed
  30. Gandhi GY, Kovalaske M, Kudva Y, Walsh K, Elamin MB, Beers M, Coyle C, Goalen M, Murad MS, Erwin PJ, Corpus J, Montori VM, Murad MH. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol. 2011 Jul; 5(4):952-65. Epub 2011 Jul 01. 2187714
    View PubMed
  31. Rostambeigi N, Lanza IR, Dzeja PP, Deeds MC, Irving BA, Reddi HV, Madde P, Zhang S, Asmann YW, Anderson JM, Schimke JM, Nair KS, Eberhardt NL, Kudva YC. Unique cellular and mitochondrial defects mediate FK506-induced islet beta-cell dysfunction. Transplantation. 2011 Mar 27; 91(6):615-23. 2141508
    View PubMed
  32. Kudva YC, Basu A. Elevated HbA1c levels (5.7% to 6.4%) had low accuracy for diagnosing prediabetes. ACP J Club. 2011 Mar 20; 154(3):10. 2190935
  33. Kudva YC, Basu A. ACP Journal Club. Elevated HbA1c levels (5.7% to 6.4%) had low accuracy for diagnosing prediabetes. Ann Intern Med. 2011 Mar 15; 154(6):JC3-11. 2162185
    View PubMed
  34. Kudva YC, Basu A. Ultra-long-acting insulins for a lifestyle-related pandemic. Lancet. 2011 Mar 12; 377(9769):880-1. 2152023
    View PubMed
  35. Thatava T, Nelson TJ, Edukulla R, Sakuma T, Ohmine S, Tonne JM, Yamada S, Kudva Y, Terzic A, Ikeda Y. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Ther. 2011 Mar; 18(3):283-93. Epub 2010 Nov 04. 2124070
    View PubMed
  36. Thatava T, Armstrong AS, De Lamo JG, Edukulla R, Khan YK, Sakuma T, Ohmine S, Sundsbak JL, Harris PC, Kudva YC, Ikeda Y. Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Res Ther. 2011; 2(6):48. Epub 2011 Dec 06. 2216592
    View PubMed
  37. Pattan V, Parsaik AK, Brown JK, Kudva YC, Vlahakis N, Basu A. Mayo Clinic Experience: Insulin Infusion Protocol with significantly reduced Hypoglycemia in the Intensive Care Unit. Journal of Diabetes Science and Technology (. 2011; In Press). 2214871
  38. Hiddinga HJ, Sakagashira S, Ishigame M, Madde P, Sanke T, Nanjo K, Kudva YC, Lee JL, van Deursen J, Eberhardt NL. Expression of wild-type and mutant S20G hIAPP in physiologic knock-in mouse models fails to induce islet amyloid formation, but induces mild glucose intolerance. Journal of Diabetes Investigation J Diab Invest (. 2011; In Press). 2214872
  39. Spanogle JP, Kudva YC, Dierkhising RA, Kremers WK, Roenigk RK, Brewer JD, Prieto M, Otley CC. Skin Cancer Following Pancreas Transplant. Journal of the American Academy of Dermatology (. 2011; In Press). 2214873
  40. Parsaik AK, Carter RE, Pattan V, Myers LA, Kumar H, Smith SA, Russi CS, Levine JA, Basu A, Kudva YC. Population Based Study of Severe Hypoglycemia requiring Emergency Medical Service Assistance reveals Unique Findings. J Diab Sci Tech (. 2011; In Press). 2214874
  41. Dong M, Parsaik AK, Eberhardt NL, Basu A, Cosio FG, Kudva YC. Cellular and Physiologic Mechanisms of New Onset Diabetes Mellitus after Solid Organ Transplantation. Diab Med (. 2011; In Press). 2214865
  42. Thatava T, Armstrong A, De Lamo JG, Edukulla R, Sakuma T, Ohmine S, Sundsbak J, Harris PC, Kudva YC, Ikeda Y. Successful disease-specific iPS cell generation from patients with kidney transplantation. Stem Cell Research and Therapy (. 2011; In Press). 2214876
  43. Saad A, Dalla Man C, Nandy DK, Levine JA, Bharucha AE, Rizza RA, Basu R, Cobelli C, Kudva YC, Basu A. Circadian Pattern to Insulin Secretion and Insulin Action in healthy individuals. Diabetes (. 2011; revision submitted). 2214880
  44. Ohmine S, Dietz AB, Deeds MC, Hartjes KA, Miller DR, Thatava T, Sakuma T, Kudva YC, Ikeda Y. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells. Stem Cell Res Ther. 2011; 2(6):46. Epub 2011 Nov 16. 2210854
    View PubMed
  45. Parsaik AK, Murad MH, Sathananthan A, Moorthy V, Erwin PJ, Chari S, Carter RE, Farnell MB, Vege SS, Sarr MG, Kudva YC. Metabolic and target organ outcomes after total pancreatectomy: Mayo Clinic experience and meta-analysis of the literature. Clin Endocrinol (Oxf). 2010 Dec; 73(6):723-31. 2114940
    View PubMed
  46. Rostambeigi N, Kudva YC, John S, Mailankody S, Pedersen RA, Dean PG, Prieto M, Cosio FG, Kremers WK, Walker RC, Abraham RS, Stegall MD. Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation. Transplantation. 2010 May 15; 89(9):1126-33. 1987803
    View PubMed
  47. Eckel-Passow JE, Mahoney DW, Oberg AL, Zenka RM, Johnson KL, Nair KS, Kudva YC, Bergen HR III, Therneau TM. Bi-linear regression for 18O quantification: Modeling across the elution profile. Journal of Proteomics and Bioinformatics. 2010; 3(12):323-9. 2147841
  48. Issa N, Amer H, Dean PG, Kremers WK, Kudva YC, Rostambeigi N, Cosio FG, Larson TS, Habermann TM, Stegall MD, Griffin MD. Posttransplant lymphoproliferative disorder following pancreas transplantation. Am J Transplant. 2009 Aug; 9(8):1894-902. Epub 2009 Jun 10. 1949894
    View PubMed
  49. Winters JL, Tran SA, Gastineau DA, Padley DJ, Dean PG, Kudva YC. Organ procurement organization compliance with 21 CFR 1271: a challenge for allogeneic pancreatic islet cell transplantation programs. Am J Transplant. 2009 Jun; 9(6):1472-6. Epub 2009 May 13. 1944211
    View PubMed
  50. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab. 2009 Mar; 94(3):729-40. Epub 2008 Dec 16. 1915088
    View PubMed
  51. Fatourechi M, Kudva YC, Hassan Murad M, Tabini C, Montori VM. Intensive insulin therapy with continuous subcutaneous insulin infusion versus multiple daily injections: systematic review and meta-analysis of randomized controlled trials. J Clin Endo Metab ePub. Dec. 2008. 1913294
  52. Gandhi GY, Murad MH, Flynn DN, Elamin MB, Erwin PJ, Montori VM, Kudva YC. Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials. Clin Endocrinol (Oxf) 2008 Aug; 69(2):244-52. Epub 2008 Jan 10. 1909517
    View PubMed
  53. Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr; 31(4):643-7. Epub 2008 Jan 09. 1892609
    View PubMed
  54. Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant. 2008 Mar; 8(3):593-9. 1872215
    View PubMed
  55. Dean PG, Kudva YC, Stegall MD. Long-term benefits of pancreas transplantation. Curr Opin Organ Transplant. 2008 Feb; 13(1):85-90. 1898930
    View PubMed
  56. Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD. Posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant. 2008 Jan; 8(1):175-82. Epub 2007 Oct 31. 1861354
    View PubMed
  57. Rajagopalan G, Mangalam AK, Sen MM, Kudva YC, David CS. Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes. Autoimmunity. 2007 Nov; 40(7):489-96. 1867440
    View PubMed
  58. Ajaz F, Kudva YC, Erwin PJ. Residual dysphasia after severe hypoglycemia in a patient with immune-mediated primary adrenal insufficiency and type 1 diabetes mellitus: case report and systematic review of the literature. Endocr Pract. 2007 Jul-Aug; 13(4):384-8. 1931468
    View PubMed
  59. Rajagopalan G, Mangalam AK, Sen MM, Cheng S, Kudva YC, David CS. Autoimmunity in HLA-DQ8 transgenic mice expressing granulocyte/macrophage-colony stimulating factor in the beta cells of islets of Langerhans. Autoimmunity. 2007 May; 40(3):169-79. 1824722
    View PubMed
  60. Kudva YC, Basu A, Jenkins GD, Pons GM, Vogelsang DA, Rizza RA, Smith SA, Isley WL. Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin. Endocr Pract. 2007 May-Jun; 13(3):244-50. 1828132
    View PubMed
  61. Pissios P, Ozcan U, Kokkotou E, Okada T, Liew CW, Liu S, Peters JN, Dahlgren G, Karamchandani J, Kudva YC, Kurpad AJ, Kennedy RT, Maratos-Flier E, Kulkarni RN. Melanin concentrating hormone is a novel regulator of islet function and growth. Diabetes. 2007 Feb; 56(2):311-9. 1856306
    View PubMed
  62. Kudva YC, Basu A, Jenkins GD, Pons GM, Quandt LL, Gebel JA, Vogelsang DA, Smith SA, Rizza RA, Isley WL. Glycemic Variation and Hypoglycemia in well controlled patients with type 1 diabetes on Multiple Daily Insulin Injection Program using Glargine and Ultralente as basal insulin. Diabetes Research and Clin Practice. 2007. 1825701
  63. Anderson JM, Deeds MC, Armstrong AS, Gastineau DA, Kudva YC. Utilization of a test gradient enhances islet recovery from deceased donor pancreases. Cytotherapy. 2007; 9(7):630-6. 1858411
    View PubMed
  64. Kudva YC, Basu A. Adjunctive inhaled insulin before meals improved glycaemic control more than adjunctive metformin in type 2 diabetes mellitus. Evid Based Med. 2006 Dec; 11(6):176. 1815047
    View PubMed
  65. Rajagopalan G, Kudva YC, Sen MM, Marietta EV, Murali N, Nath K, Moore J, David CS. IL-10-deficiency unmasks unique immune system defects and reveals differential regulation of organ-specific autoimmunity in non-obese diabetic mice. Cytokine. 2006 Apr; 34(1-2):85-95. 1769912
    View PubMed
  66. Mahmud FH, Murray JA, Kudva YC, Zinsmeister AR, Dierkhising RA, Lahr BD, Dyck PJ, Kyle RA, El-Youssef M, Burgart LJ, Van Dyke CT, Brogan DL, Melton LJ 3rd. Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc. 2005 Nov; 80(11):1429-34. 1733737
    View PubMed
  67. Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, Stegall MD. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 2005 Jun; 67(6):2415-21. 1720367
    View PubMed
  68. Heimbach JK, Taler SJ, Prieto M, Cosio FG, Textor SC, Kudva YC, Chow GK, Ishitani MB, Larson TS, Stegall MD. Obesity in living kidney donors: Clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant. 2005 May; 5(5):1057-64. 1705165
    View PubMed
  69. Kudva Y, Hunt D. Trandolapril delayed persistent microalbuminuria in hypertension, type 2 diabetes, and normoalbuminuria. ACP J Club. 2005 May-Jun; 142(3):65. 1733891
    View PubMed
  70. Kudva YC, Basu A, Jenkins GD, Pons GM, Quandt LL, Gebel JA, Vogelsang DA, Smith SA, Rizza RA, Isley WL. Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes. Diabetes Care. 2005 Jan; 28(1):10-4. 1680804
    View PubMed
  71. Krajicek BJ, Kudva YC. Hurley HA. Potentially important contribution of dextrose used as diluent to hyperglycemia in hospitalized patients Diabetes Care. 2005; 28(4):981-2. 2214868
  72. Montori VM, Helgemoe PK, Guyatt GH, Dean DS, Leung TW, Smith SA, Kudva YC. Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care. 2004 May; 27(5):1088-94. 1644339
    View PubMed
  73. Larson TS, Bohorquez H, Rea DJ, Nyberg SL, Prieto M, Sterioff S, Textor SC, Schwab TR, Griffin MD, Gloor JM, Kudva YC, Kremers WK, Stegall MD. Pancreas-after-kidney transplantation: An increasingly attractive alternative to simultaneous pancreas-kidney transplantation. Transplantation. 2004 Mar 27; 77(6):838-43. 1641250
    View PubMed
  74. Kudva YC, Sawka AM, Young WF. Clinical review 164 - The laboratory diagnosis of adrenal pheochromocytoma: The Mayo Clinic experience. J Clin Endocrinol Metab. 2003 Oct 1; 88(10):4533-9. 1420014
    View PubMed
  75. Rajagopalan G, Kudva YC, Chen LP, Wen L, David CS. Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans. Int Immunol. 2003 Sep; 15(9):1035-44. 1413551
    View PubMed
  76. Kudva YC. Antimicrobial treatment did not reduce complications of urinary tract infection in diabetes and asymptomatic bacteriuria. ACP J Club. 2003 May-Jun; 138(3):69. 1652639
    View PubMed
  77. Zangeneh F, Kudva YC, Basu A. Insulin sensitizers. Mayo Clin Proc. 2003 Apr; 78(4):471-9. 1328698
    View PubMed
  78. Kudva YC, Reynolds CA, O'Brien T, Crotty TB. Mastopathy and diabetes. Current Diabetes Reports. 2003 Feb; 3(1):56-9. 1642926
    View PubMed
  79. Rajagopalan G, Kudva YC, Flavell RA, David CS. Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules. Diabetes. 2003 Feb; 52(2):342-7. 1318574
    View PubMed
  80. Kudva YC. A split regimen for regular insulin at dinner and NPH insulin at bedtime reduced nocturnal hypoglycemia in type 1 diabetes. ACP J Club. 2002 Nov-Dec; 137(3):89. 1652473
    View PubMed
  81. Kudva YC, Rajagopalan G, Raju R, Abraham RS, Smart M, Hanson J, David CS. Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II. Hum Immunol. 2002 Nov; 63(11):987-99. 1316681
    View PubMed
  82. Kudva YC. Review: intensive insulin pump therapy slightly improves glycemic control in type 1 diabetes. ACP J Club. 2002 Sep-Oct; 137(2):56. 1652477
    View PubMed
  83. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes - A systematic review of the literature. Diabetes Care. 2002 Mar; 25(3):583-92. 1008354
    View PubMed
  84. Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB. "Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. Diabetes Care. 2002 Jan; 25(1):121-6. 1007943
    View PubMed
  85. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF Jr. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab. 2001 Nov; 86(11):5210-6. 1007005
    View PubMed
  86. Kudva YC, Deng YJ, Govindarajan R, Abraham RS, Marietta EV, Notkins AL, David CS. HLA-DQ8 transgenic and NOD mice recognize different epitopes within the cytoplasmic region of the tyrosine phosphatase-like molecule, IA-2. Hum Immunol. 2001 Oct; 62(10):1099-105. 1967446
    View PubMed
  87. Kudva YC, Deng Y, Govindrajan R, Abraham RS, Marietta E, Notkins AL, David CS. The Cytoplasmic Region of IA-2 are Immunogenic in NOD and HLA DQ8 Transgenic Mice. Human Immunol. 2001; 62(10):1099-105. 1825702
  88. Abraham RS, Kudva YC, Wilson SB, Strominger JL, David CS. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes. 2000 Apr; 49(4):548-54. 131602
    View PubMed
  89. Stegall MD, Larson TS, Kudva YC, Grande JP, Nyberg SL, Prieto M, Velosa JA, Rizza RA. Pancreas transplantation for the prevention of diabetic nephropathy. Mayo Clin Proc. 2000 Jan; 75(1):49-56. 127087
    View PubMed
  90. Kudva YC, O'Brien T, Crotty TB. Sclerosing lymphocytic lobulitis or "diabetic mastopathy" is specific for type 1 diabetes mellitus. Diabetes Care. 2000. 1139180
  91. Kudva YC, Young WF, Thompson GB, Grant CS, van Heerden JA. Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. Endocrinologist. 1999 Mar-Apr; 9(2):77-80. 112466
  92. Kudva YC, Mueske C, Butler PC, Eberhardt NL. A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation. Biochem J. 1998 May 1; 331 ( Pt 3):809-13. 105490
    View PubMed
  93. Kudva YC, Mueske CS, Butler PC, Eberhardt NL. Effect of Insulin Secretory Vesicle Constituents on Human Islet Amyloid Polypeptide (IAPP) Amyloidogenesis in an In vitro Fluorescence Assay. Biochem J 331 809-13,. 1998. 2214864
  94. Kudva YC, Gharib H. Thyroid nodules: approaches to diagnosis and management. Endocr Updates. 1998; 2:139-154. 115119
  95. Kudva YC, Young WF Jr. Lightheaded spells and hypertension. Lancet. 1997 Oct 18; 350(9085):1140. 100420
    View PubMed
  96. Kudva YC, Hiddinga HJ, Butler PC, Mueske CS, Eberhardt NL. Small heat shock proteins inhibit in vitro A beta(1-42) amyloidogenesis. FEBS Lett. 1997 Oct 13; 416(1):117-21. 100622
    View PubMed
  97. Kudva YC, Peterson LS, Holley KE, Wright AJ, Hunder GG. SLE nephropathy in a patient with HIV infection: case report and review of the literature. J Rheumatol. 1996 Oct; 23(10):1811-5. 97950
    View PubMed
  98. Kudva YC, Mason TG. 22-year-old man with abdominal pain and rash. Mayo Clin Proc. 1996 May; 71(5):489-92. 95182
    View PubMed
  99. Chintapatla S, Kudva YC, Nayar RC, Raghuveer TS, Prasad D. Septal deviation in neonates. Indian Pediatr. 1989 Jul; 26(7):678-82. 1046592
    View PubMed